VIM and cancer: Besides individual CRCs, CTM which displayed CD45-/PD-L1+/CD31-/Vimentin- phenotypes was also detected in diagnosed cancer patients’ peripheral blood (Figure 3F), and for the non-neoplastic infectious patients, we could only observe CTM with no biomarker expression (Figure 3G).